Philip Morris wraps up $820m acquisition of Danish CDMO Fertin Pharma
Philip Morris International (PMI) has wrapped up its previously announced DKK 5.1 billion ($820 million) acquisition of Fertin Pharma, a Danish a specialist contract development and manufacturing organization (CDMO), from EQT Mid Market. The deal was announced in July 2021. Founded by the Bagger-Sørensen family, Fertin Pharma develops and manufactures pharmaceutical and well-being products based […]